JHJennifer S. Harthan

Jennifer S. Harthan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jennifer S. Harthan has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Complications of Poorly Fitted Scleral Lenses and Approaches to Continued Wear

    by Cherie B. Nau, Amy C. Nau, Jennifer S. Fogt, Ellen S. Shorter, Jennifer S. Harthan, Muriel M. Schornack

    Scleral lenses (SLs) are increasingly considered a mainstream option for optical correction in patients with corneal irregularity and for protection of the ocular surface in patients with ocular surface disease. However, there can be complications with SL if the fit and disease is not regularly monitored. This case series reviews complications from poorly fitted SLs. Changes in SL design may allow a patient to resume successful lens wear. Regardless, SL fit and underlying disease states should be assessed at regularly scheduled intervals for new concerns in all patients and for recurrence of problems despite modification of fit in those who suffer complications.

  • Open Access

    Presence of Eyelid Disease in Habitual Scleral Lens Wearers

    by Jennifer S. Harthan, Amy Nau, Ellen Shorter, Cherie B. Nau, Muriel Schornack, Jennifer Swingle Fogt

    Background/Objectives: As scleral lens (SL) use continues to expand, particularly for medically necessary management of corneal irregularity and ocular surface disease, it is important to determine if wear of these lenses is associated with eyelid disease. This study evaluated habitual SL wearers for meibomian gland obstruction, meibum quality, and signs of lid margin inflammation. Methods: Eligible participants wore scleral lenses in one or both eyes for any indication and had been wearing their current lens design(s) for at least six months, with habitual wear of ≥5 h per day, six days per week. Eyelid inflammation metrics were specifically assessed. Results: Forty-nine scleral lens wearers (32 females) were enrolled. Upper lid wiper epitheliopathy (LWE) was present in 21 eyes (43%), and lower LWE was present in 15 eyes (31%). Thirty-nine eyes (80%) had expressible meibomian glands. Eyes with no expressible meibum were significantly higher in ocular surface disease (39%, 7/18) than corneal irregularity (11%, 3/27) (p = 0.03). Lid margin telangiectasia was present in wearers with ocular surface disease (61%, 11/18) and corneal irregularity (19%, 5/26) (p = 0.005). Conclusions: Eyelid disease was common among habitual scleral wearers regardless of indication for lens use. Eyes with ocular surface disease demonstrated a higher prevalence of meibomian gland obstruction and lid margin telangiectasia compared to those with corneal irregularity.

  • Open Access

    Fluid Reservoir Characteristics in Established Scleral Lens Wear, Part I—Evaluation of Fluid Reservoir Depth and Midday Fogging

    by Jennifer Swingle Fogt, Muriel Schornack, Ellen Shorter, Jennifer S. Harthan, Amy Nau, Cherie Nau

    Objectives: Fluid reservoir (FR) depth is an important parameter in the evaluation of scleral lens fitting, yet the range of depths compatible with successful wear, clinicians' ability to estimate depth, and implications of FR depth on midday fogging have yet to be fully elucidated. This study quantified FR depth of habitual scleral lens wearers, compared clinician estimates and image-based measurements of depth, and evaluated optical density of the FR to assess the effect of FR depth on midday fogging. Methods: Habitual scleral lens wearers consented to participate at three sites. FR depth was estimated using slitlamp evaluation by experienced examiners. Measurements of the depth and optical density of the FR were collected using Scheimpflug images. Results: The mean estimated (265±97; range: 0–500 µm) and image-derived (264±111; range: 40–555 µm) FR depths were not statistically different ( P =0.9). No correlation was found between optical density and depth of the FR. Conclusion: Successful scleral lens wear can occur with a wide range of FR depths. Experienced practitioners can accurately estimate FR depth using slitlamp examination. Midday fogging due to debris behind a scleral lens was not related to FR depth in this group of habitual wearers.

  • Open Access

    Fluid Reservoir Characteristics in Established Scleral Lens Wear, Part II: Evaluation of Tear Exchange and Midday Fogging

    by Jennifer Swingle Fogt, Ellen Shorter, Jennifer S. Harthan, Cherie Nau, Amy Nau, Muriel Schornack

    Objectives: Tear exchange is less robust with scleral lenses compared to other modalities. This study evaluates tear exchange with scleral lens wear and examines relationships between tear exchange and optical density of the fluid reservoir and patient-reported midday fogging in established scleral lens wearers. Methods: Participants reported if they experienced midday fogging. Tear exchange was evaluated by observing sodium fluorescein uptake into the post-lens fluid reservoir after 10 seconds, and 1, 2.5, and 5 minutes. Optical density of the fluid reservoir was measured using Scheimpflug imaging. Sensitivity, specificity, and negative and positive predictive value (NPV and PPV) of tear exchange as a predictor for fogging were calculated. Results: Tear exchange occurred within 5 minutes in 64% of eyes. The difference in fluid reservoir optical density for eyes with and without tear exchange was greatest when tear exchange occurred within 10 seconds. Tear exchange between 1-5 minutes was not predictive for fogging. Tear exchange occurring within 10 seconds showed low sensitivity and NPV, but high specificity (87%) and PPV (71%) for predicting fogging. Conclusion: Tear exchange occurred in a majority of eyes in this study. Scleral lens wearers with a rapid tear exchange rate were more likely to report midday fogging.

  • Open Access

    Revised Calculation of the Prevalence of Keratoconus Based on Updated Scheimpflug Corneal Tomography Metrics in a Pediatric Population From a Chicago-Based School Age Vision Clinic

    by Michael W. Belin, Jennifer S. Harthan, S. Barry Eiden, Andrew S. Morgenstern, William Tullo, John D. Gelles, Sandra S. Block, Steven Greenstein, Peter S. Hersh


  • Open Access

    Clinical Safety and Efficacy of Orthokeratology Contact Lenses With Toric Peripheral Curves: A Review of the Literature

    by Langis O.D. Michaud, Jennifer O.D. Harthan, Ayda Shahidi, Marjorie Rah, William O.D. Reindel

    Objective: To assess the clinical safety and efficacy of orthokeratology (OK) lenses with toric peripheral curves (TPCs), based on a review of published literature. Methods: A literature search on OK lenses with TPCs using 11 relevant search term combinations was conducted. Databases included PubMed, Cochrane Online Library, Prospero International Prospective Register of Systematic Reviews, and Embase. The period covered was January 1, 2012, to May 1, 2024. Results: In total, 600 publications were identified in the search databases using the search criteria. Based on titles and abstracts, 52 distinct articles were identified for further review; of these, 16 were determined related to clinical evaluation of OK lenses with TPCs. The published studies involved five different lens models from five different manufacturers: Menicon Z Night Toric (Menicon Co, Ltd, Nagoya, Japan), Euclid Emerald Toric (Euclid Systems Corporation, Herndon, VA), Lucid Night Ortho-K Toric (Lucid Korea, Seoul, Korea), Dual Axis Corneal Refractive Therapy (Paragon Vision Sciences, Gilbert, AZ), and Eyebright Base Curve Aspheric Ortho-K (Eyebright Medical Technology Co, Ltd, Beijing, China). Conclusions: Published literature suggests that OK lenses with TPCs are effective in treating patients with both myopia and astigmatism, with favorable safety profiles.


  • Image- and impression-based technology for scleral lens fitting for keratoconus: Efficiency of the fitting process

    by Ellen Shorter, Jennifer Fogt, Cherie Nau, Jennifer Harthan, Amy Nau, Muriel Schornack


  • Prevalence of Keratoconus Based on Scheimpflug Corneal Tomography Metrics in a Pediatric Population From a Chicago-Based School Age Vision Clinic

    by Jennifer S. O.D. Harthan, John D. O.D. Gelles, Sandra S. O.D. Block, William O.D. Tullo, Andrew S. O.D. Morgenstern, Becky O.D. Su, Daniel B.A. Chung, Austin B.S. Yu, Steven A. Greenstein, Peter S. Hersh, et al.

    Purpose: Determine the pediatric prevalence of keratoconus (KC) using Scheimpflug corneal tomography. Methods: A prospective observational study was done on subjects aged 3 to 18 years at the Princeton Vision Clinic, Chicago, IL. Scheimpflug tomography (Pentacam HR, OCULUS Optikgerate GmbH) scans (Belin/Ambrósio Enhanced Ectasia BAD3) yielded BAD Final D (Final D) and Back Elevation at the Thinnest Point (BETP) measurements. Criteria differentiating non-KC from KC suspects & KC were, Non- KC—Final D KC suspect—Final D ≥2.00 and KC—Final D of ≥3.00 with BETP ≥18 μm for myopia or ≥28 μm for hyperopia/mixed astigmatism in at least one eye. Two thousand two hundred and six subjects were recorded, removing duplicate and poor-quality scans leaving 2007 subjects. Results: Of 2007 subjects, six were classified as KC—prevalence of 1:334, three subjects were KC suspects—prevalence of 1:669, and total prevalence of KC suspects and KC was 1:223. Conclusion: The prevalence of KC in children is higher than previously reported, emphasizing the importance of sensitive screening for KC at its earliest manifestation as standard in pediatric comprehensive eye examinations.


  • Natural history of adenoviral conjunctivitis in a US-based population: Viral load, signs, and symptoms

    by Jennifer S. Harthan, Tammy Than, Ellen Shorter, Andrew T.E. Hartwick, Christina E. Morettin, Julia B. Huecker, Spencer D. Johnson, Mary K. Migneco, Meredith Whiteside, Christian K. Olson, et al.


  • Open Access

    Correlation of Adenoviral Titers with Severity of Adenoviral Conjunctivitis and Time to Viral Clearance for 21 Days

    by Christina E. Morettin, Jennifer S. Od Harthan, Julia B. Huecker, Chamila D. Perera, Tammy Od Than, Meredith Od Whiteside, Spencer D. Od Johnson, Ellen Od Shorter, Mary K. Od Migneco, Christian K. Od Olson, et al.

    SIGNIFICANCE: This investigation reports the correlation of conjunctival viral titers in adenoviral conjunctivitis with patient‐reported symptoms and clinician‐graded signs for 21 days of follow‐up. PURPOSE: Adenoviral conjunctivitis is a highly contagious viral eye infection with significant morbidity and economic impact. This study investigates whether severity of signs and symptoms and time to viral clearance are correlated with conjunctival viral titers at baseline and during 21 days of follow‐up. METHODS: The Reducing Adenoviral Patient Infected Days study was a pilot study of the efficacy of a single in‐office administration of ophthalmic 5% povidone‐iodine. This article outlines longitudinal analyses after the primary outcome report. Of 212 participants screened, 28 participants with quantitative polymerase chain reaction–confirmed adenoviral conjunctivitis were randomized and had follow‐up visits on days 1, 2, 4, 7, 14, and 21. At each visit, clinician‐graded signs, participant‐reported symptoms, and a conjunctival swab for quantitative polymerase chain reaction analysis were obtained. The correlation of viral titers with symptoms and signs was calculated: (1) cross‐sectionally at each visit and (2) longitudinally for 21 days using a repeated‐measures mixed‐effects model. RESULTS: Twenty‐five of 28 participants had sufficient data for this report. Higher viral titers for 21 days were correlated with greater severity of symptoms (tearing, matting, and redness, r ≥ 0.70; P <. 02) and greater severity of clinical signs (bulbar redness and serous discharge, r ≥ 0.60; P <. 01). Eyes with highest baseline viral titers required longer time to viral clearance ( r = 0.59, P =. 008). Signs and symptoms persisted in approximately half of the eyes even after viral clearance. CONCLUSIONS: Higher conjunctival viral titers across 21 days were strongly correlated with more severe signs and symptoms and longer time to viral clearance. Our results also indicate that symptoms and signs can persist after viral clearance.